Epidemiology, Health Economic Context, and Management of Chronic Kidney Diseases in Low and Middle-Income Countries: The Case of Morocco

*Omar Maoujoud,1,2 Yahia Cherrah,1 Mohammed Arrayhani,2 Nadir Zemraoui,3 Hocein Dkhissi,4 Driss El Kabbaj,5 Oualim Zouhair,6 Karim Filali,7 Samir Ahid1

1. Research Team of Pharmacoepidemiology and Pharmacoeconomics, Medical and Pharmacy School, Mohammed V University, Rabat, Morocco
2. Department of Nephrology, Faculty of Medicine, Ibn Zohr University, Agadir, Morocco
3. Department of Nephrology and Dialysis, Avicenne Military Hospital Marrakech, Marrakech, Morocco
4. Meknes Dialysis Center, Meknes, Morocco
5. Department of Nephrology and Dialysis, Mohammed V Military Hospital, Rabat, Morocco
6. Idriss Al Akbar dialysis Center, Rabat, Morocco
7. Department of Intensive Care Unit, First MedicoSurgical Hospital, Agadir, Morocco
*Correspondence to maoujoud@gmail.com

Disclosure: The authors have declared no conflicts of interest. The results presented in this paper have not been published previously in whole or part, except in abstract format.
Received: 29.12.16 Accepted: 26.06.17
Citation: EMJ. 2017;2[4]:76-81.

Abstract

Background: There is a significant emerging burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in low and middle-income countries. Nonetheless, despite these trends, knowledge of CKD epidemiology and management remains incomplete. This review presents a critical analysis and comparison of the current data related to CKD epidemiology in Morocco and an overview of the health economic context of the management of ESRD.

Main text: In Morocco, the demographic transition occurring as a result of urbanisation, population ageing, and the global epidemic of diabetes exposes a growing number of people with CKD who are consuming a significant proportion of healthcare budgets. While the real prevalence of ESRD may be underestimated due to limited access to medical coverage for a fraction of the population, the growing costs in the face of limited resources may shortly compromise the healthcare system.

Conclusion: Based on the available data, the prevalence of CKD may grow during the coming decades, according to the increasing prevalence of its major risk factors (diabetes, hypertension, and older age). Thus, early diagnosis, treatment of the underlying cause, and implementation of preventive measures are fundamental for CKD patients.

This article is made available under the terms of theĀ Creative Commons Attribution-Non Commercial 4.0 License.

Download (PDF, 88KB)

Comments are closed.